🕵️ Inogen Inc ($INGN)
SEC insider & ownership activity, last 12 months · CIK 1294133 · every row links its SEC filing
Over the last 12 months insiders sold $142K with no open-market buying against it. Jennifer Yi Boyer sold $142K through a 10b5-1 trading plan in 2 lots (May–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $142K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jennifer Yi Boyer | 0 | – | 2 | $142K | Jul 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Yuwell (HONG KONG) Holdings Limited | 9.9% | 13G | Feb 24, 2025 | filing ↗ | |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 9.9% | 13G | Feb 24, 2025 | filing ↗ | |
| Blackrock, Inc. | 6.2% | 13G | Jul 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jennifer Yi Boyer | $71K | Jul 1, 2026 | filing ↗ |
| Jennifer Yi Boyer | $70K | May 29, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 20, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |